USA Equities Corp. Introduces AllergiQT™ – Quick Test, Further Expanding Market Presence
29. November 2021 08:00 ET
|
USA Equities Corp
FDA-cleared and Easily Administered Skin Test for Environmental and Food Allergens; AllergiQT™ – Quick Test Targets Non-Allergy Specialists in Primary Care SettingsStrengthens USA Equities...
USA Equities Corp. Announces Third Quarter 2021 Financial Results And Conversion of Secured Convertible Promissory Note
16. November 2021 07:30 ET
|
USA Equities Corp
● Revenue Surpassed $1 million for Nine Months of 2021 Compared to $0 for the Same Period 2020 ● Gross Margin of 48% in Q3 Increased 290 Basis Points Versus Q2 2021 ● Issuance of 76,923 Shares...
USA Equities Corp. Launches Q-Scale Product to Meet Growing Mental Health End Market Demand
19. Oktober 2021 08:30 ET
|
USA Equities Corp
Strengthening Business Model and Expanding Product Portfolio in Large Addressable End MarketQ-Scale Represents a Compelling and Reimbursable Value Proposition for USAQ’s Physician ClientsFurther...
USA Equities Corp. Issues Updated September 2021 Investor Presentation
22. September 2021 08:30 ET
|
USA Equities Corp
●Superior Business Model and Strategic Position Validated By Growing Client Base and Product Portfolio ●Addressable Market Opportunity Includes Over 250,000 Independent Primary Care...
USA Equities Corp. Announces Strong Second Quarter 2021 Results
17. August 2021 08:30 ET
|
USA Equities Corp
Second Quarter 2021 Financial Results In-Line with July Pre-AnnouncementSuccessful $750,000 Capital Raise Increases Financial Flexibility to Execute on Growth StrategyAcquired AllergiEnd® Assets...
Allergies in Primary Care: A Study of the Allergy Management Evaluation Tool Published on Consultant360 Specialty Network
05. August 2021 07:59 ET
|
USA Equities Corp
-USA Equities Corp. Business Model and Strategic Direction Favorably Aligned with Industry Growth Drivers-West Palm Beach, FL, Aug. 05, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a...
USA Equities Corp. Announces Strong Second Quarter 2021 Financial Results
15. Juli 2021 07:30 ET
|
USA Equities Corp
● Revenue Grew 50% to $456,219 Compared to Q1 2021 ● Gross Margin of 46% Increased 164 Basis Points Versus Q1 2021 ● Strengthening of Company Financial Position and Strategic Relationships West Palm...
USA Equities Corp Announces the Signing of a Distribution Agreement with a Prominent Physician Management Services Firm For its AllergiEnd® Products and Services
29. Juni 2021 07:30 ET
|
USA Equities Corp
-Continued Momentum Expanding Independent Care Practitioner Network- West Palm Beach, FL, June 29, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on value-based...
USA Equities Corp. Acquires AllergiEnd®Assets
24. Juni 2021 07:00 ET
|
USA Equities Corp
●Acquisition Strengthens USAQ Business Model and Strategic Position●Purchase includes AllergiEnd® Method Patent, Trademark and Website●AllergiEnd®’s Product Portfolio Favorably Aligned with Industry...
USA Equities Corp Announces Co-Promotion Agreement with ENP Network for AllergiEnd® and Upcoming University of Miami CME Workshop
09. Juni 2021 08:00 ET
|
USA Equities Corp
-Further Expanding Independent Practitioner Network and Industry Visibility- West Palm Beach, FL, June 09, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on...